POSTOPERATIVE ADJUVANT CHEMOTHERAPY FOR GASTRIC CANCER

摘要

A method of treating gastric cancer that is a postoperative adjuvant chemotherapy for gastric cancer characterized by comprising orally administering to a patient suffering from gastric cancer in stage II, IIIA or IIIB in the classification of the extent of gastric cancer a medicinal composition, which contains Tegafur, Gimeracil and Oteracil potassium at a molar ratio of 1:0.4:1, in a dose of 50 to 150 mg/day in terms of Tegafur according to a dosing schedule consisting of, from within 45 days after the surgical operation, 28 consecutive days of administration followed by a 7- to 14-day drug holiday. This postoperative adjuvant chemotherapy reduces the rate of recurrence of gastric cancer after surgical operation and elevates the survival rate.